Developmental differences in dopamine synthesis inhibition by (±)-7-OH-DPAT

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 356, Issue 2, 1997, Pages 173-181

  Andersen, Susan L ^a   Dumont, Nathalie L ^a   Teicher, Martin H ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

( ) 7 OH DPAT; Autoreceptor; D3; Dopamine (DA); Ontogeny; Synthesis

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3 HYDROXYBENZYLHYDRAZINE; AUTORECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; ETICLOPRIDE; GAMMA BUTYROLACTONE; LEVODOPA; QUINPIROLE;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DRUG ANTAGONISM; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MATURATION; NONHUMAN; NUCLEUS ACCUMBENS; ONTOGENY; PREFRONTAL CORTEX; RAT; RECEPTOR AFFINITY; SYNTHESIS;

AGE FACTORS; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FEMALE; LEVODOPA; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; TETRAHYDRONAPHTHALENES;

EID: 0030859902     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005038     Document Type: Article

References (45)

1. Andersen SL, Gazzara RA (1993) The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: I. Effects on spontaneous release. J Neurochem 61 : 12247-2255
2. Andersen SL, Gazzara RA (1994 a) The development of D2 autoreceptor-mediated modulation of potassium-evoked dopamine release in the neostriatum. Dev Brain Res 78 : 123-130
3. Andersen SL, Gazzara RA (1994 b) Development of the autoreceptor reserve in rats. Neurosci Abstr 20 : 643
4. Andersen SL, Gazzara RA (1996) Effects of (-) sulpiride on dopamine release in striatum of developing rats: Degree of depolarization influences responsiveness. J Neurochem 67 : 1931-1937
5. Babigian HM (1980) Schizophrenia: Epidemiology. In: Kaplan HI, Freedman AM, Sadock BJ (eds) Comprehensive Textbook of Psychiatry/III. Williams & Wilkins, Baltimore, pp 1115-1117
6. Baldessarini RJ, Kula NS, McGrath CR, Bakthavachala V, Kebabaian JW, Neumeyer JL (1993) Isomeric selectivity at dopamine D3 receptors. Eur J Pharmacol 239 : 269-270
7. Bannon MJ, Michaud RL, Roth RH (1981) Mesocortical dopamine neurons. Lack of autoreceptors modulating dopamine synthesis. Mol Pharmacol 19 : 270-275
8. Bannon MJ, Reinhard Jr JR, Bunney EB, Roth RH (1982) Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurons. Nature 296 : 444-446
9. Bannon MJ, Wolf MA, Roth RH (1983) Pharmacology of dopamine neurons innervating the prefrontal, cingulate, and piriform corticies. Eur J Pharmacol 91 : 119-125
10. Booth RG, Baldessarini RJ (1990) Adenosine A2 stimulation of tyrosine hydroxylase in rat striatal minces is reversed by dopamine D2 autoreceptor activation. Eur J Pharmacol 185 : 217-221
11. Booth RG, Baldessarini RJ (1991) (+)-6,7-Benzomorphan sigma ligands stimulate dipamine synthesis in the rat corpus striatum tissue. Brain Res 447 : 349-352
12. Booth RG, Baldessarini RJ, Marsh E, Owens C (1994) Actions of (±)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain. Brain Res 662 : 283-288
13. Boundy VA, Luedtke RR, Gallitano AL, Smith JE, Filiz TM, Kallen RG, Molinoff PB (1993) Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies. J Pharmacol Exp Ther 264 : 1002-1011
14. Campbell A, Baldessarini RJ, Teicher MH (1988) Decreasing sensitivity to neuroleptic agents in developing rats: Evidence for a pharmacodynamic factor. Psychopharmacology 94 : 46-51
15. DeLean A, Munson PJ, Robard D (1978) Simultaneous analysis of families of sigmoid curves: application to bioassay, radioligand, and physiological dose-response curves. Am J Physiol 4 : E97-102
16. DeVries TJ, Hogenboom F, Mulder AH, Schoffelmeer ANM (1992) Ontogeny of mu, sigma, and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain. Dev Brain Res 54 : 63-69
17. Engberg G, Nissbrandt H (1993) gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors. Nauyn-Schmiedberg's Arch Pharmacol 348 : 491-497
18. Feinberg I (1982-3) Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J Psychiat Res 17 : 319-334
19. Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS (1996) In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis. Eur J Pharmacol 308 : 261-269
20. Gelbard HA, Teicher MH, Faedda G, Baldessarini RJ (1989) Postnatal development of dopamine D1 and D2 receptor sites in rat striatum. Dev Brain Res 49 : 123-130
21. Hedner T, Lundborg P (1985) Development of dopamine autoreceptors in the postnatal rat brain. J Neural Transm 62 : 53-63
22. Heilig M, Vecsei L, Wahlestedt C (1990) Effects of centrally administered neuropeptide Y (NPY) and NPY 13-36 on the brain monoaminergic systems of the rat. J Neural Transm 79 : 193-208
23. Hetier E, Boireau A, Bubedat P (1988) Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens, and prefrontal cortex in rat. Naunyn-Schmiedeberg's Arch Pharmacol 337 : 13-17
24. Hoffman RE, Dobscha SK (1989) Cortical pruning and the development of schizophrenia: a computer model. Schizop Bull 15 : 477-490
25. Huttenlocher PR (1979) Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Res 163 : 195-205
26. Kalsner S (1990) Heteroreceptors, autoreceptors, and other terminal sites. In: Kalsner S, Westfall T (eds) Presynaptic receptors and the question of autoregulation of neurotransmitter release. Ann New York Acad Sci 604 : 1-42
27. Keshaven M, Anderson S, Pettegrew JW (1994) Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiat Res 28 : 239-264
28. Levesque D, Diza J, Pilon C, Martres MP, Giros B, Souil E, Schott D, Morgat JL, Schwartz JC, Sokoloff P (1992) Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89 : 8155-8159
29. Lewine RRJ (1988) Gender and schizophrenia. In: Tsuang MT, Simpson JC (eds) Handbook of Schizophrenia: Nosology, Epidemiology and Genetics of Schizophrenia, vol. 3. Elsevier, Amsterdam, pp 379-397
30. Lidow MS, Goldman-Rakic PS, Rakic P (1991) Synchronized over production of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc Natl Acad Sci USA 88 : 10 218-10221
31. Onali P, Olianas MC, Bunse B (1988) Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes. Brain Res 456 : 302-303
32. Rakic P, Bourgeoi JP, Eckenhoff MF, Zecevic N, Goldman-Rakic PS (1986) Concurrent over production of synapses in diverse regions of the primate cerebral cortex. Science 232 : 232
33. Seeman P, Bzowej N, Guan H, Bergeron C, Becker LE, Reynolds GP, Bird ED, Riederer P, Jellinger K, Watanabe S, Tourtellotte WW (1987) Human brain receptors in children and aging adults. Synapse 1 : 399-404
34. Shalaby I, Spear LP (1980) Psychopharmacological effects of low and high doses of apomorphine during ontogeny. Eur J Pharmacol 67 : 451-459
35. Shalaby I, Dendel PS, Spear LP (1981) Differential functional ontogeny of dopamine presynaptic receptor regulation. Dev Brain Res 1 : 434-439
36. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347 : 146-151
37. Teicher MH, Barber NI, Gelbard HA, Galittano AL, Campbell A, Marsh E, Baldessarini RJ (1993) Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. Neuropsychopharmacology 9 : 147-156
38. Teicher MH, Barber NI, Reichheld JH, Baldessarini RJ, Finkelstein SP (1986) Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rats. Dev Brain Res 30 : 124-128
39. Teicher MH, Baldessarini RJ (1987) Developmental pharmacodynamics. In: Popper C (ed) Psychiatric pharmacosciences of adolescents and children. APA Monograph Series, APA Press, pp 45-80
40. Teicher MH, Gallitano AL, Gelbard HA, Evans HK, Marsh E, Booth RG, Baldessarini RJ (1991) Dopamine D1 autoreceptor function: possible expression in developing rat prefrontal cortex and striatum. Dev Brain Res 63 : 229-235
41. Teicher MH, Andersen SL, Hostetter JC (1995) Evidence for dopamine receptor pruning in corpus striatum but not in nucleus accumbens. Dev Brain Res 89 : 167-172
42. VanTol HHM, Bunzow JR, Guan HG, Sunahara RK, Seeman P, Niznik H, Civelli O (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 347 : 76-78
43. Walters JR, Roth RH (1976) Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch Phamacol 296 : 5-14
44. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiat 44 : 660-664
45. Wolf ME, Galloway MP, Roth RH (1986) Regulation of dopamine synthesis in the medial prefrontal cortex: Studies in brain slices. J Pharmacol Exp Ther 236 : 699-707